Progesterone and Bone: Actions Promoting Bone Health in Women
Open Access
- 1 January 2010
- journal article
- Published by Wiley in Journal of Osteoporosis
- Vol. 2010, 1-18
Abstract
Estradiol () and progesterone () collaborate within bone remodelling on resorption () and formation (). We integrate evidence that may prevent and, with antiresorptives, treat women's osteoporosis. stimulates osteoblast differentiationin vitro. Menarche () and onset of ovulation () both contribute to peak BMD. Meta-analysis of 5 studies confirms that regularly cycling premenopausal women lose bone mineral density (BMD) related to subclinical ovulatory disturbances (SODs). Cyclic progestin prevents bone loss in healthy premenopausal women with amenorrhea or SOD. BMD loss is more rapid in perimenopause than postmenopause—decreased bone formation due to deficiency contributes. In 4 placebo-controlled RCTs, BMD loss is not prevented by in postmenopausal women with increased bone turnover. However, 5 studies of -MPA co-therapy show greater BMD increases versus alone. fracture data are lacking. prevents bone loss in pre- and possibly perimenopausal women; progesterone co-therapy with antiresorptives may increase bone formation and BMD.Keywords
This publication has 105 references indexed in Scilit:
- Lean Body Mass, Not Estrogen or Progesterone, Predicts Peak Bone Mineral Density in Premenopausal Women –The Journal of Nutrition, 2009
- Vasomotor symptoms in infertile premenopausal women: a hitherto unappreciated risk for low bone mineral densityFertility and Sterility, 2008
- Osteoimmunology: Interactions of the Bone and Immune SystemEndocrine Reviews, 2008
- Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort studyBreast Cancer Research and Treatment, 2007
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With HysterectomyJAMA, 2004
- Breast cancer and hormone-replacement therapy in the Million Women StudyThe Lancet, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Die normale und gestörte Funktion des Corpus luteumReproduktionsmedizin, 1998
- A double‐blind randomised controlled trial of the effects of medroxyprogesterone acetate on bone density of women taking oestrogen replacement therapyBJOG: An International Journal of Obstetrics & Gynaecology, 1997
- Stimulatory effects of estrogen and progesterone on proliferation and differentiation of normal human osteoblast-like cells in vitroBiochemical and Biophysical Research Communications, 1992